Aryl Hydrocarbon Receptor in Breast Cancer-A Newly Defined Prognostic Marker

Hormones and Cancer

Volumn 5, Issue 1, 2014, Pages 11-21

  Saito, Ryoko ^a   Miki, Yasuhiro ^a   Hata, Shuko ^a   Takagi, Kiyoshi ^a   Iida, Shinya ^a   Oba, Yuki ^a   Ono, Katsuhiko ^a   Ishida, Takanori ^b   Suzuki, Takashi ^a   Ohuchi, Noriaki ^b   Sasano, Hironobu ^a  

^a TOHOKU UNIVERSITY SCHOOL OF MEDICINE   (Japan)

^b TOHOKU UNIVERSITY HOSPITAL   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

2,3,7,8 TETRACHLORODIBENZO PARA DIOXIN; AROMATIC HYDROCARBON RECEPTOR; ESTROGEN; ESTROGEN RECEPTOR; MATRIX METALLOPROTEINASE;

ADULT; ARTICLE; BREAST CARCINOMA; CARCINOMA CELL; CELL MIGRATION; DISEASE MARKER; FEMALE; HUMAN; HUMAN CELL; HUMAN TISSUE; IMMUNOCYTOCHEMISTRY; IMMUNOREACTIVITY; MIDDLE AGED; PRIORITY JOURNAL; PROTEIN EXPRESSION; WOUND HEALING;

ADULT; AGED; AGED, 80 AND OVER; BREAST NEOPLASMS; CARCINOMA, DUCTAL; CELL MOVEMENT; CELL PROLIFERATION; ESTROGENS; FEMALE; HUMANS; IMMUNOHISTOCHEMISTRY; MATRIX METALLOPROTEINASES; MCF-7 CELLS; MIDDLE AGED; PROGNOSIS; PROTEIN ARRAY ANALYSIS; RECEPTORS, ARYL HYDROCARBON; SIGNAL TRANSDUCTION; TETRACHLORODIBENZODIOXIN; TUMOR MARKERS, BIOLOGICAL;

EID: 84892454964     PISSN: 18688497     EISSN: 18688500     Source Type: Journal    
DOI: 10.1007/s12672-013-0160-z     Document Type: Article

References (44)

1. Abdelrahim M, Smith R 3rd, Safe S (2003) Aryl hydrocarbon receptor gene silencing with small inhibitory RNA differentially modulates Ah-responsiveness in MCF-7 and HepG2 cancer cells. Mol Pharmacol 63(6): 1373-1381.
2. Adachi J, Mori Y, Matsui S, Takigami H, Fujino J, Kitagawa H, Miller CA 3rd, Kato T, Saeki K, Matsuda T (2001) Indirubin and indigo are potent aryl hydrocarbon receptor ligands present in human urine. J Biol Chem 276(34): 31475-31478.
3. Beischlag TV, Luis Morales J, Hollingshead BD, Perdew GH (2008) The aryl hydrocarbon receptor complex and the control of gene expression. Crit Rev Eukaryot Gene Expr 18(3): 207-250.
4. Bertazzi PA, Zocchetti C, Guercilena S, Consonni D, Tironi A, Landi MT, Pesatori AC (1997) Dioxin exposure and cancer risk: a 15-year mortality study after the "Seveso accident". Epidemiology 8(6): 646-652.
5. Caldarella A, Crocetti E, Bianchi S, Vezzosi V, Urso C, Biancalani M, Zappa M (2011) Female breast cancer status according to ER, PR and HER2 expression: a population based analysis. Pathol Oncol Res 17(3): 753-758.
6. Chang JT, Chang H, Chen PH, Lin SL, Lin P (2007) Requirement of aryl hydrocarbon receptor overexpression for CYP1B1 up-regulation and cell growth in human lung adenocarcinomas. Clin Cancer Res 13(1): 38-45.
7. Denison MS, Nagy SR (2003) Activation of the aryl hydrocarbon receptor by structurally diverse exogenous and endogenous chemicals. Annu Rev Pharmacol Toxicol 43: 309-334.
8. Denison MS, Soshilov AA, He G, DeGroot DE, Zhao B (2011) Exactly the same but different: promiscuity and diversity in the molecular mechanisms of action of the aryl hydrocarbon (dioxin) receptor. Toxicol Sci 124(1): 1-22.
9. Dietrich C, Kaina B (2010) The aryl hydrocarbon receptor (AhR) in the regulation of cell-cell contact and tumor growth. Carcinogenesis 31(8): 1319-1328.
10. Dolwick KM, Schmidt JV, Carver LA, Swanson HI, Bradfield CA (1993) Cloning and expression of a human Ah receptor cDNA. Mol Pharmacol 44(5): 911-917.
11. Elston CW, Ellis IO (1991) Pathological prognostic factors in breast cancer. I The value of histological grade in breast cancer: experience from a large study with long-term follow-up Histopathology 19(5): 403-410.
12. Figueira RC, Gomes LR, Neto JS, Silva FC, Silva ID, Sogayar MC (2009) Correlation between MMPs and their inhibitors in breast cancer tumor tissue specimens and in cell lines with different metastatic potential. BMC Cancer 9: 20.
13. Gierthy JF, Bennett JA, Bradley LM, Cutler DS (1993) Correlation of in vitro and in vivo growth suppression of MCF-7 human breast cancer by 2, 3, 7, 8-tetrachlorodibenzo-p-dioxin. Cancer Res 53(13): 3149-3153.
14. Hall JM, Barhoover MA, Kazmin D, McDonnell DP, Greenlee WF, Thomas RS (2010) Activation of the aryl-hydrocarbon receptor inhibits invasive and metastatic features of human breast cancer cells and promotes breast cancer cell differentiation. Mol Endocrinol 24(2): 359-369.
15. Harper PA, Riddick DS, Okey AB (2006) Regulating the regulator: factors that control levels and activity of the aryl hydrocarbon receptor. Biochem Pharmacol 72(3): 267-279.
16. Ishida M, Mikami S, Kikuchi E, Kosaka T, Miyajima A, Nakagawa K, Mukai M, Okada Y, Oya M (2010) Activation of the aryl hydrocarbon receptor pathway enhances cancer cell invasion by upregulating the MMP expression and is associated with poor prognosis in upper urinary tract urothelial cancer. Carcinogenesis 31(2): 287-295.
17. Kim SH, Henry EC, Kim DK, Kim YH, Shin KJ, Han MS, Lee TG et al (2006) Novel compound 2-methyl-2H-pyrazole-3-carboxylic acid (2-methyl-4-o-tolylazo-phenyl)-amide (CH-223191) prevents 2, 3, 7, 8-TCDD-induced toxicity by antagonizing the aryl hydrocarbon receptor. Mol Pharmacol 69(6): 1871-1878.
18. Klinge CM, Bowers JL, Kulakosky PC, Kamboj KK, Swanson HI (1999) The aryl hydrocarbon receptor (AHR)/AHR nuclear translocator (ARNT) heterodimer interacts with naturally occurring estrogen response elements. Mol Cell Endocrinol 157(1-2): 105-119.
19. Larsen MC, Angus WG, Brake PB, Eltom SE, Sukow KA, Jefcoate CR (1998) Characterization of CYP1B1 and CYP1A1 expression in human mammary epithelial cells: role of the aryl hydrocarbon receptor in polycyclic aromatic hydrocarbon metabolism. Cancer Res 58(11): 2366-2374.
20. Laurinavicius A, Laurinaviciene A, Ostapenko V, Dasevicius D, Jarmalaite S, Lazutka J (2012) Immunohistochemistry profiles of breast ductal carcinoma: factor analysis of digital image analysis data. Diagn Pathol 7(1): 27.
21. Lin P, Chang H, Tsai WT, Wu MH, Liao YS, Chen JT, Su JM (2003) Overexpression of aryl hydrocarbon receptor in human lung carcinomas. Toxicol Pathol 31(1): 22-30.
22. Lin PH, Lin CH, Huang CC, Chuang MC, Lin P (2007) 2, 3, 7, 8-Tetrachlorodibenzo-p-dioxin (TCDD) induces oxidative stress, DNA strand breaks, and poly(ADP-ribose) polymerase-1 activation in human breast carcinoma cell lines. Toxicol Lett 172(3): 146-158.
23. Mandal PK (2005) Dioxin: a review of its environmental effects and its aryl hydrocarbon receptor biology. J Comp Physiol B 175(4): 221-230.
24. Marlowe JL, Puga A (2005) Aryl hydrocarbon receptor, cell cycle regulation, toxicity, and tumorigenesis. J Cell Biochem 96(6): 1174-1184.
25. Mason ME, Okey AB (1982) Cytosolic and nuclear binding of 2, 3, 7, 8-tetrachlorodibenzo-p-dioxin to the Ah receptor in extra-hepatic tissues of rats and mice. Eur J Biochem 123(1): 209-215.
26. Merlo S, Sortino MA (2012) Estrogen activates matrix metalloproteinases-2 and -9 to increase beta amyloid degradation. Mol Cell Neurosci 49(4): 423-429.
27. Morrow D, Qin C, Smith R 3rd, Safe S (2004) Aryl hydrocarbon receptor-mediated inhibition of LNCaP prostate cancer cell growth and hormone-induced transactivation. J Steroid Biochem Mol Biol 88(1): 27-36.
28. Nguyen LP, Bradfield CA (2008) The search for endogenous activators of the aryl hydrocarbon receptor. Chem Res Toxicol 21(1): 102-116.
29. Nilsson UW, Garvin S, Dabrosin C (2007) MMP-2 and MMP-9 activity is regulated by estradiol and tamoxifen in cultured human breast cancer cells. Breast Cancer Res Treat 102(3): 253-261.
30. Ohtake F, Takeyama K, Matsumoto T, Kitagawa H, Yamamoto Y, Nohara K, Tohyama C et al (2003) Modulation of oestrogen receptor signalling by association with the activated dioxin receptor. Nature 423(6939): 545-550.
31. Pellikainen JM, Ropponen KM, Kataja VV, Kellokoski JK, Eskelinen MJ, Kosma VM (2004) Expression of matrix metalloproteinase (MMP)-2 and MMP-9 in breast cancer with a special reference to activator protein-2, HER2, and prognosis. Clin Cancer Res 10(22): 7621-7628.
32. Peng TL, Chen J, Mao W, Song X, Chen MH (2009) Aryl hydrocarbon receptor pathway activation enhances gastric cancer cell invasiveness likely through a c-Jun-dependent induction of matrix metalloproteinase-9. BMC Cell Biol 10: 27.
33. Pesatori AC, Consonni D, Rubagotti M, Grillo P, Bertazzi PA (2009) Cancer incidence in the population exposed to dioxin after the "Seveso accident": twenty years of follow-up. Environ Health 8: 39.
34. Pliskova M, Vondracek J, Vojtesek B, Kozubik A, Machala M (2005) Deregulation of cell proliferation by polycyclic aromatic hydrocarbons in human breast carcinoma MCF-7 cells reflects both genotoxic and nongenotoxic events. Toxicol Sci 83(2): 246-256.
35. Prud'homme GJ, Glinka Y, Toulina A, Ace O, Subramaniam V, Jothy S (2010) Breast cancer stem-like cells are inhibited by a non-toxic aryl hydrocarbon receptor agonist. PLoS One 5(11): e13831.
36. Safe S, McDougal A (2002) Mechanism of action and development of selective aryl hydrocarbon receptor modulators for treatment of hormone-dependent cancers (review). Int J Oncol 20(6): 1123-1128.
37. Safe S, Wormke M, Samudio I (2000) Mechanisms of inhibitory aryl hydrocarbon receptor-estrogen receptor crosstalk in human breast cancer cells. J Mammary Gland Biol Neoplasia 5(3): 295-306.
38. Seidel SD, Winters GM, Rogers WJ, Ziccardi MH, Li V, Keser B, Denison MS (2001) Activation of the Ah receptor signaling pathway by prostaglandins. J Biochem Mol Toxicol 15(4): 187-196.
39. Tanaka G, Kanaji S, Hirano A, Arima K, Shinagawa A, Goda C, Yasunaga S et al (2005) Induction and activation of the aryl hydrocarbon receptor by IL-4 in B cells. Int Immunol 17(6): 797-805.
40. Villano CM, Murphy KA, Akintobi A, White LA (2006) 2, 3, 7, 8-Tetrachlorodibenzo-p-dioxin (TCDD) induces matrix metalloproteinase (MMP) expression and invasion in A2058 melanoma cells. Toxicol Appl Pharmacol 210(3): 212-224.
41. Wang WL, Porter W, Burghardt R, Safe SH (1997) Mechanism of inhibition of MDA-MB-468 breast cancer cell growth by 2, 3, 7, 8-tetrachlorodibenzo-p-dioxin. Carcinogenesis 18(5): 925-933.
42. Wolff S, Harper PA, Wong JM, Mostert V, Wang Y, Abel J (2001) Cell-specific regulation of human aryl hydrocarbon receptor expression by transforming growth factor-beta(1). Mol Pharmacol 59(4): 716-724.
43. Wormke M, Stoner M, Saville B, Walker K, Abdelrahim M, Burghardt R, Safe S (2003) The aryl hydrocarbon receptor mediates degradation of estrogen receptor alpha through activation of proteasomes. Mol Cell Biol 23(6): 1843-1855.
44. Zhang S, Lei P, Liu X, Li X, Walker K, Kotha L, Rowlands C, Safe S (2009) The aryl hydrocarbon receptor as a target for estrogen receptor-negative breast cancer chemotherapy. Endocr Relat Cancer 16(3): 835-844.